PAG
GILD icon

Private Advisor Group’s Gilead Sciences GILD Stock Holding History

Private Advisor Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-37,700
Closed -$28.3K – 2335
2023
Q3 		$28.3K Buy
+37,700
New +$2.9M ﹤0.01% 2073
2015
Q1 		– Sell
-400
Closed -$3K – 1030
2014
Q4 		$3K Buy
+400
New +$41.4K ﹤0.01% 992

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Private Advisor Group's GILD Position: Q2 2026 in Review

Private Advisor Group reduced its Gilead Sciences (GILD) stake by 13% in Q2 2026, selling an estimated $827K and leaving 43,759 shares worth $5.53M. The position accounts for 0.03% of the portfolio, ranked #583.

Private Advisor Group first reported a position in GILD in Q4 2013 and has held it in 51 quarters since. The position peaked at $9.76M in Q3 2021. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Private Advisor Group held 43,759 shares of Gilead Sciences worth $5.53M as of Q2 2026.
  • Private Advisor Group sold 6,276 Gilead Sciences shares in Q2 2026, an estimated $827K.
  • Gilead Sciences made up 0.03% of Private Advisor Group's portfolio in Q2 2026, its #583 holding.
  • Private Advisor Group first reported a position in Gilead Sciences in Q4 2013 and has held it in 51 quarters since.
  • Private Advisor Group's Gilead Sciences position peaked at $9.76M in Q3 2021.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.